IDEX IDEX BIOMETRICS ASA

IDEX Biometrics ASA: Interim statement of financial position as of 1 January 2025

IDEX Biometrics ASA: Interim statement of financial position as of 1 January 2025

IDEX Biometrics ASA (“IDEX” or “Company”) released its preliminary financial statements for 2024 on 27 February 2025. Subsequently, on 11 March 2025, the Company announced its revised business strategy plan. The Company has reviewed its assets and business in view of this strategy. Certain equipment items have been written down and an obsolescence provision has been recognised on inventory, and other, minor adjustments have been made. The total effect for the IDEX Biometrics group on the consolidated result for 2024 and the consolidated net equity as of 31 December 2024 amounted to an increased loss of USD 1.6 million and lower equity by the same amount. This will be reflected in the annual financial statements for 2024 to be issued on 30 April 2025.

In the separate parent company financial statements for the parent company, IDEX Biometrics ASA, an additional write-down on investments in subsidiaries amounting to USD 5.7 million was recognized. This adjustment does not impact the consolidated result or equity for the IDEX Biometrics group. 

An interim statement of financial position (Norwegian: Mellombalanse) for the parent company as of 1 January 2025 has been prepared for the purpose of the extraordinary general meeting on 11 April 2025 to consider the board’s proposal to reduce the share capital. The interim statement of financial position is attached to this notice. Please refer to the separate notice of the extraordinary general meeting.

For further information contact:

Marianne Bøe, Head of Investor Relations, Tel:

Kristian Flaten, CFO, Tel:

E-mail:

About IDEX Biometrics:

IDEX Biometrics ASA (IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit .

About this notice:

This notice was published by Kristian Flaten, CFO, 21 March 2025 at 16:35 CET on behalf of IDEX Biometrics ASA.  This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12.

Attachment



EN
21/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX BIOMETRICS ASA

 PRESS RELEASE

Disclosure of Voting Rights in IDEX Biometrics to Chair, Morten Opstad...

Disclosure of Voting Rights in IDEX Biometrics to Chair, Morten Opstad – 07 April 2025 At the close of business on 07 April 2025, Morten Opstad, chair of the board of IDEX Biometrics, held the following voting rights in IDEX, for the extraordinary general meeting on 11 April 2025. Total 142,779,329 shares or 17.17% of the share capital and votes, including shares held by Mr. Opstad and close relations. Some of the proxies may include voting instructions. Contact personsMarianne Bøe, Head of Investor Relations, Tel.: +47 918 00186Kristian Flaten, CFO, Tel.: +47 950 92322E-mail: ...

 PRESS RELEASE

IDEX Biometrics ASA - Information about the second exercise period for...

IDEX Biometrics ASA - Information about the second exercise period for warrants (Warrants B) issued in connection with the Private Placement and Subsequent Offering NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE ANNOUNCEMENT. Oslo, Norway – 31 March 2025 - Reference...

 PRESS RELEASE

Disclosure of Voting Rights in IDEX Biometrics to Chair, Morten Opstad...

Disclosure of Voting Rights in IDEX Biometrics to Chair, Morten Opstad – 31 March 2025 At the close of business on 31 March 2025, Morten Opstad, chair of the board of IDEX Biometrics, held the following voting rights in IDEX, for the extraordinary general meeting on 11 April 2025. Total 63,760,705 shares or 7.37% of the share capital and votes, including shares held by Mr. Opstad and close relations. Some of the proxies may include voting instructions. Contact personsMarianne Bøe, Head of Investor Relations, Tel.: +47 918 00186Kristian Flaten, CFO, Tel.: +47 950 92322E-mail: Ab...

 PRESS RELEASE

Registration of share capital increase in IDEX Biometrics 24 March 202...

Registration of share capital increase in IDEX Biometrics 24 March 2025 Reference is made to the announcement by IDEX Biometrics ASA on 18 March 2025 regarding the results of the exercise of Warrants A. A total of 17,258 Warrants A were exercised, resulting in an aggregate subscription for 17,258 new shares, each Warrant A having an exercise price of NOK 0.15. The share capital increase has been registered in the Norwegian Register of Business Enterprises. Following the issue, IDEX Biometrics ASA share capital is NOK 124,739,134.80, divided into 831,594,232 shares, each with a nominal val...

 PRESS RELEASE

IDEX Biometrics ASA: Interim statement of financial position as of 1 J...

IDEX Biometrics ASA: Interim statement of financial position as of 1 January 2025 IDEX Biometrics ASA (“IDEX” or “Company”) released its preliminary financial statements for 2024 on 27 February 2025. Subsequently, on 11 March 2025, the Company announced its revised business strategy plan. The Company has reviewed its assets and business in view of this strategy. Certain equipment items have been written down and an obsolescence provision has been recognised on inventory, and other, minor adjustments have been made. The total effect for the IDEX Biometrics group on the consolidated result fo...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch